Francesco Nobile
Bianchi, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation.
Journal: Bone marrow transplantation
Published: August 18, 2014
Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.
Journal: American journal of hematology
Published: December 18, 2013
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 04, 2013
Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile.
Journal: Leukemia research
Published: August 25, 2013
Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia.
Journal: Leukemia
Published: August 21, 2013
Lenalidomide in International Prognostic Scoring System Low and Intermediate-1 risk myelodysplastic syndromes with del(5q): an Italian phase II trial of health-related quality of life, safety and efficacy.
Journal: Leukemia & lymphoma
Published: February 26, 2013
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy.
Journal: British journal of haematology
Published: January 17, 2013
Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study.
Journal: Annals of hematology
Published: June 03, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026